When it comes to gene editing technologies like CRISPR, the initial applications were focused around just that, the capability to edit and alter gene sequences. The main efforts after were to enhance the specificity of this activity and to improve further what could be changed. But in recent years we’ve begun to see an expansion […]
Abstract By Brigette Corder, Sterling Ericsson, and Taylor Uhlir The CRISPR-Cas systems are a new and exciting tool for research and scientific discovery. Here we discuss and compare the various CRISPR-Cas systems and report current uses for these systems by concentrating a principal spotlight on CRISPR-Cas 10. From CRISPR’s rudimentary beginnings in the form of […]
The specificity found within the mechanisms of the CRISPR system can be both a boon and a bane. Thanks to things like the PAM sequence, CRISPR-Cas9 has found itself as a useful tool to accurately target desired gene sequences at an unparalleled level. No other gene editing technology can really come close to matching the […]
As things change, they ultimately stay the same. Or perhaps a better metaphor is that we always end up circling back to the beginning, retracing our own footsteps. That seems to be the case today, though not in a bad way. The Early Bloom One of the very first original biotech experiments back in the […]
The research into new forms of CRISPR seems never-ending. It is an ongoing goal of scientists around the world to expand scientific knowledge on different kinds of CRISPR and also creating newfound capabilities for the existing varieties. Since the greater the flexibility of the tools available to science, the more treatments and medicines that can […]
In a previous article, we discussed how CRISPR is not almighty and that organisms can evolve resistance to the changes made to their genome. The simplest method for them to accomplish this is just to mutate the changed gene back to what it was before or just stop its function altogether. If the change made […]
A Historical Viewpoint The Explosion Onto The Public Stage For those focused on how history will favor the uncovering of CRISPR and the miraculous developments that have and will spawn from it, the first thing to note is that the idea and research into the technology started several years prior to its explosion into the […]
The other day on Bioscription, we discussed the South Korean Institute for Basic Science (IBS) and their work with CRISPR-Cpf1 in soybeans. Today, the same organization has released a study on a new form of CRISPR-Cas9 that they isolated from Campylobacter jejuni. This resulted in the acronym CjCas9 for it. A Problem Of Size A […]
